Novel approaches for the treatment of unresectable malignant pleural mesothelioma: A focus on immunotherapy and target therapy (Review)-Reference-Cited by-同舟云学术

Novel approaches for the treatment of unresectable malignant pleural mesothelioma: A focus on immunotherapy and target therapy (Review)

Published:2022-02-22 Issue:4 Volume:16 Page:
ISSN:2049-9450
Container-title:Molecular and Clinical Oncology
language:
Short-container-title:Mol Clin Oncol

Author:

Rijavec Erika¹,Biello Federica²,Barletta Giulia³,Dellepiane Chiara³,Genova Carlo⁴

Affiliation:

1. Medical Oncology Unit, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, I‑20122 Milan, Italy

2. Department of Translational Medicine, Division of Oncology, University of Eastern Piemonte, I‑28100 Novara, Italy

3. Medical Oncology Unit, IRCCS Ospedale Policlinico San Martino, I‑16132 Genoa, Italy

4. Academic Oncology Unit, IRCCS Ospedale Policlinico San Martino, I‑16132 Genoa, Italy

Publisher

Spandidos Publications

Subject

Cancer Research,Oncology

Reference50 articles.

1. Emerging biological therapies for the treatment of malignant pleural mesothelioma;Davis;Expert Opin Emerg Drugs,2021

2. Lung cancer * 8: Management of malignant mesothelioma;Parker;Thorax,2003

3. Guidelines for pathologic diagnosis of malignant mesothelioma 2017 update of the consensus statement from the International mesothelioma interest group;Husain;Arch Pathol Lab Med,2018

4. First-line nivolumab plus ipilimumab in unresectable malignant pleural mesothelioma (CheckMate 743): A multicentre, randomised, open-label, phase 3 trial;Baas;Lancet,2021

5. First-line nivolumab (NIVO) plus ipilimumab (IPI) versus chemotherapy (chemo) for the treatment of unresectable malignant pleural mesothelioma (MPM): Patient-reported outcomes (PROs) from CheckMate 743;Scherpereel;Ann Oncol,2020

Cited by 11 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Patient characteristics, treatment patterns, and survival outcomes for patients with malignant pleural mesothelioma in Denmark between 2011 and 2018: a nationwide population-based cohort study;Acta Oncologica;2024-08-08

2. Specific Targeting of Mesothelin-Expressing Malignant Cells Using Nanobody-Functionalized Magneto-Fluorescent Nanoassemblies;International Journal of Nanomedicine;2024-01

3. Three distinct mechanisms underlying human γδ T cell-mediated cytotoxicity against malignant pleural mesothelioma;Frontiers in Immunology;2023-03-17

4. Medical application of the monoclonal antibody SKM9-2 against sialylated HEG1, a new precision marker for malignant mesothelioma;Proceedings of the Japan Academy, Series B;2023-02-10

5. Deep dive into the immune response against murine mesothelioma permits design of novel anti-mesothelioma therapeutics;Frontiers in Immunology;2023-01-04